Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
CERACELL Foam
- Development stage
- Unknown
- Lead developer
- Curasan
- Modality
- Nanoparticles → Drug Delivery Systems, Device-based Delivery → Drug Delivery Systems, Hydrogel Systems → Drug Delivery Systems
- Administration
- Implant
01
Overview
CERACELL Foam is a bone graft substitute medical device developed by Curasan, designed as a collagen-ceramic composite biomaterial. It consists of bioactive, silicated beta-tricalcium phosphate (β-TCP) granules (containing 4% silicate) embedded within a porcine type 1 collagen matrix. The device functions as an osteoconductive scaffold that supports bone healing and regeneration by providing an interconnected porous structure that facilitates cellular infiltration, vascularization, and tissue integration. The silicated β-TCP component promotes osteointegration and mimics natural hydroxyapatite formation, while the collagen matrix provides structural support and promotes osteoblast attachment. CERACELL Foam is intended for surgical implantation and intraoperative topical application to bone defects in spinal surgery (including cervical and lumbar fusion), orthopedic surgery, trauma, and dental applications. It is designed to fully resorb and be replaced by autologous bone within 6 to 12 months.
- Brand names
- CERACELL Foam
- Other names
- CERACELLcollagen-ceramic composite
Beyond the preview
Go deeper on CERACELL Foam.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on CERACELL Foam.